FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 230 filers reported holding FIBROGEN INC in Q1 2019. The put-call ratio across all filers is 11.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $560,000 | -17.5% | 15,124 | +0.7% | 0.03% | -20.6% |
| Q2 2019 | $679,000 | -16.9% | 15,025 | 0.0% | 0.03% | -10.5% |
| Q1 2019 | $817,000 | +17.6% | 15,025 | 0.0% | 0.04% | +5.6% |
| Q4 2018 | $695,000 | -23.9% | 15,025 | 0.0% | 0.04% | -33.3% |
| Q3 2018 | $913,000 | -3.0% | 15,025 | 0.0% | 0.05% | -10.0% |
| Q2 2018 | $941,000 | +35.6% | 15,025 | 0.0% | 0.06% | +27.7% |
| Q1 2018 | $694,000 | -2.5% | 15,025 | 0.0% | 0.05% | -13.0% |
| Q4 2017 | $712,000 | -11.9% | 15,025 | 0.0% | 0.05% | -26.0% |
| Q3 2017 | $808,000 | -57.5% | 15,025 | +71.9% | 0.07% | -47.1% |
| Q2 2017 | $1,900,000 | -6.8% | 8,743 | -70.4% | 0.14% | -19.3% |
| Q1 2017 | $2,039,000 | +39.2% | 29,534 | +8.6% | 0.17% | +17.1% |
| Q4 2016 | $1,465,000 | +99.6% | 27,201 | -37.7% | 0.15% | -4.6% |
| Q3 2016 | $734,000 | – | 43,678 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 605,713 | $9,703,522 | 5.73% |
| ARMISTICE CAPITAL, LLC | 3,864,000 | $61,901,280 | 1.08% |
| Logos Global Management LP | 525,000 | $8,410,500 | 0.98% |
| 5AM Venture Management, LLC | 225,583 | $3,613,840 | 0.97% |
| Intercontinental Wealth Advisors, LLC | 191,300 | $3,064,626 | 0.91% |
| BHK Investment Advisors, LLC | 87,550 | $1,402,551 | 0.79% |
| Integral Health Asset Management, LLC | 175,000 | $2,803,500 | 0.59% |
| Nan Fung Group Holdings Ltd | 34,106 | $546,378 | 0.38% |
| Soleus Capital Management, L.P. | 113,463 | $1,817,677 | 0.26% |
| Point72 Asset Management, L.P. | 4,781,645 | $76,601,953 | 0.26% |